Strong foundations, exceptional results
Upstream bioprocessing and downstream bioanalytical testing.
Bringing together our expertise and passion, our team will be available to discuss how our bioprocessing and bioanalytical solutions can help you develop safer, higher quality therapeutics. We’ll be showcasing platforms and products covering:
- Cell line development and engineering
- Cell culture and upstream processing
- Analytical, quality, and characterization
- Cell and gene therapy
Join Revvity at BPI 2025 in Boston - Booth #607
Discover bioprocessing solutions that provide your biotherapeutics with a smarter start, leading to safer outcomes.
Revvity at BPI annual meeting 2025
Analytical, quality and characterization
What’s new
HostDetect™ PCR DNA Quant Kits
These real-time PCR assays (RUO) enable quantitative detection of residual HEK293, CHO, or E. coli host genomic DNA in extracted nucleic acid samples from biopharmaceutical products.
LabChip™ Plasmid DNA (pDNA) Assay
The LabChip™ Plasmid DNA assay is designed to streamline your plasmid (pDNA) workflows. It separates the three primary isoforms of pDNA in under 2 minutes/sample while providing purity assessment based on the corrected area percentages for each conformation.
pHSense Reagents
pHSense™ probes are plate reader-compatible reagents specifically developed for internalization studies using a time-resolved fluorescence (TRF) readout. Fully compatible with our MLD platforms, pHSense enables sensitive, quantitative detection of internalization events in a high-throughput, plate-based format.
HEKcellence™ expression platform
We're looking for some most HEKcellent beta testers for this adaptable HEK293 expression system. It can produce higher quality vectors by increasing the proportion with full payloads, providing a route to lower dose requirements and ultimately reduced treatment costs and improved drug safety profiles.
Vectonize™ transgene suppression platform
Overcome production issues with our new Vectonize transgene suppression technology that prevents expression of your target sequence during production, improving or even enabling production of interfering protein payloads. Join our beta program for first access.
Scientific presentations
Streamlining residual host cell impurity monitoring in biotherapeutic products: Driving efficiency and precision
- Speaker: Anis Khimani, PhD
- Session: Analytical, Quality and Characterization
- Date: Wednesday September 17, 2025
- Time: 3:15 PM – 3:45 PM
Large molecule biotherapeutics are primarily expressed and produced in mammalian host cells. At every step of downstream bioprocess and prior to fill-finish, monitoring residual host cell impurities is critical due to their immunogenic and oncogenic risks. Regulatory agencies mandate levels of residual host cell impurities to be under acceptable limits. A workflow solution to detect low levels of residual impurities with high specificity and reliability is important to meet the critical quality attributes (CQAs) of biotherapeutic products. Here, we introduce high-performance qPCR based residual CHO or HEK293 DNA quantitation and host cell protein monitoring solutions to enable accurate and reliable monitoring and reporting of residual levels of host cell DNA and proteins in large molecule products.
Learn more
Posters
A Realtime PCR Assay for CHO Host Cell DNA Detection for Bioprocess QC
- Date: Wednesday 17th September
- Time: 10:30am - 11:25am and 3:45pm - 4:30pm
- Where: Exhibit hall
Quality Analysis of Plasmid DNA using the LabChip™ GX Touch Nucleic Acid Analyzer
- Date: Wednesday 17th September
- Time: 10:30am - 11:25am and 3:45pm - 4:30pm
- Where: Exhibit hall
For research use only. Not for use in diagnostic procedures.
The CHOSOURCE™ Platform technology is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.
LentiBOOST™ GMP Grade technology: Not for Diagnostic Use. Other applications must be authorized by a license from Revvity.
A commercial license is required for any clinical or commercial application involving AAVs developed using Revvity technologies.
HEKcellence and Vectonize are available for research, clinical, and commercialization applications, including services, under specific limited licenses from Revvity.